SCHEMBL8537598

SCHEMBL8537598

O=C(O)CN1CCN(CC(=O)O)CCN(CC(O)CCCCCCCCCOc2ccc(O)cc2)CCN(CC(=O)O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.44
MAPT P10636 2/20 0.43
L3MBTL1 Q9Y468 4/20 0.42
POLB P06746 1/20 0.42
KDM4E B2RXH2 2/20 0.41
GLA P06280 1/20 0.41
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 2/20 0.40
NR5A1 Q13285 1/20 0.40
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8537606 0.89 L3MBTL1 (0.56) MAPTL3MBTL1POLBKDM4ETSHR
SCHEMBL8482730 0.80 TSHR (0.49) L3MBTL1POLBUSP2TSHRMAPK1
SCHEMBL9315956 0.78 ITGB3 (0.40) KCNH2MAPTL3MBTL1POLBKDM4E
SCHEMBL8537604 0.78 POLB (0.41) KCNH2MAPTL3MBTL1POLBUSP2
SCHEMBL8479012 0.78 ESRRG (0.39) MAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL8482310 0.78 ALDH1A1 (0.45) L3MBTL1POLBKDM4EUSP2ALDH1A1
SCHEMBL8478983 0.77 ITGB3 (0.36) MAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL5548973 0.74 GPR84 (0.53) L3MBTL1KDM4EUSP2ALDH1A1
SCHEMBL8541852 0.74 MAPT (0.61) MAPTL3MBTL1POLBKDM4EGLA
SCHEMBL20442668 0.74 KDM4E (0.54) MAPTL3MBTL1POLBKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0485045-B1 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them SCHERING AG (DE) 1998-12-30 EP disclosed
US-5277895-A Nuclear magnetic resonance SCHERING AKTIENGESELLSCHAFT (DE) 1994-01-11 US disclosed
EP-0485045-A2 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them SCHERING AKTIENGESELLSCHAFT (DE) 1992-05-13 EP disclosed